Drugs that contain Atazanavir Sulfate; Cobicistat
1. List of Evotaz drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8148374 | BRISTOL-MYERS SQUIBB | Modulators of pharmacokinetic properties of therapeutics |
Sep, 2029
(6 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10039718 | BRISTOL-MYERS SQUIBB | Use of solid carrier particles to improve the processability of a pharmaceutical agent |
Oct, 2032
(9 years from now) | |
Market Authorisation Date: 29 January, 2015
Treatment: Treatment of hiv infection using a composition containing a pharmacokinetic enhancer that inhibits cytochrome p450 monooxygenase
Dosage: TABLET;ORAL
EVOTAZ family patents
34
United States
18
European Union
16
Japan
12
Spain
11
Hungary
10
Australia
10
Lithuania
10
Norway
10
Portugal
10
Korea, Republic of
9
Croatia
9
China
8
Denmark
8
Slovenia
8
Singapore
8
Poland
7
Hong Kong
7
Cyprus
7
EA
6
New Zealand
5
Mexico
5
AP
5
Argentina
5
RS
5
Taiwan, Province of China
5
Canada
5
ME
4
Brazil
4
Ukraine
3
Israel
2
South Africa
2
Colombia
2
Ecuador
2
Luxembourg
1
Uruguay
1
Netherlands
1
Peru
1
San Marino
1
Chile
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic